MARC details
| 000 -LEADER |
|---|
| fixed length control field |
02778nam a2200445 i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
wb9329447 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20210924135846.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
ta |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
210713t20212021enk erb 001 0deng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781529369878 |
| Qualifying information |
paperback |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781529369854 |
| Qualifying information |
hardback |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
SALS |
| Language of cataloging |
eng |
| Transcribing agency |
SALS |
| Description conventions |
rda |
| Modifying agency |
WWBK |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
614.592414 |
| Edition number |
23/eng/20210713 |
| 099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) |
|---|
| Classification number |
614.592414 |
| -- |
GIL |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Gilbert, Sarah, |
| Dates associated with a name |
1962- |
| Relator term |
author. |
| 9 (RLIN) |
115765 |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Vaxxers : |
| Remainder of title |
the inside story of the Oxford AstraZeneca vaccine and the race against the virus / |
| Statement of responsibility, etc. |
Professor Sarah Gilbert and Catherine Green ; written with Deborah Crewe. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
London : |
| Name of producer, publisher, distributor, manufacturer |
Hodder & Stoughton, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2021. |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Date of production, publication, distribution, manufacture, or copyright notice |
©2021. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
336 pages ; |
| Dimensions |
24 cm. |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent. |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
unmediated |
| Media type code |
n |
| Source |
rdamedia. |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
volume |
| Carrier type code |
nc |
| Source |
rdacarrier. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references and index. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
This is the story a race -- not against other vaccines or other scientists, but against a deadly and devastating virus. On 1 January 2020, Sarah Gilbert, Professor of Vaccinology at Oxford University, read an article about four people in China with a strange pneumonia. Within two weeks, she had designed a vaccine against a pathogen that no one had ever seen before. Less than 12 months later, vaccination was rolled out across the world to save millions of lives from Covid-19. In Vaxxers, we hear directly from Professor Gilbert and her colleague Dr Catherine Green as they reveal the inside story of making the Oxford AstraZeneca vaccine and the cutting-edge science and sheer hard work behind it. This is their story of fighting a pandemic as ordinary people in extraordinary circumstances. They share the heart-stopping moments in the eye of the storm; they separate fact from fiction; they explain how they made a highly effective vaccine in record time with the eyes of the world watching; and they give us hope for the future. Vaxxers invites us into the lab to find out how science will save us from this pandemic, and how we can prepare for the inevitable next one. |
| 600 10 - SUBJECT ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Gilbert, Sarah, |
| Dates associated with a name |
1962- |
| 9 (RLIN) |
115765 |
| 600 10 - SUBJECT ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Green, Catherine |
| Fuller form of name |
(Catherine Mary) |
| 9 (RLIN) |
115766 |
| 610 20 - SUBJECT ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
AstraZeneca (Firm) |
| 9 (RLIN) |
115767 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
COVID-19 (Disease) |
| General subdivision |
Prevention. |
| 9 (RLIN) |
115768 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
COVID-19 (Disease) |
| General subdivision |
Vaccination. |
| 9 (RLIN) |
115769 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
COVID-19 (Disease) |
| 9 (RLIN) |
115770 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Vaccines. |
| 9 (RLIN) |
115771 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Epidemics |
| General subdivision |
Prevention. |
| 9 (RLIN) |
115772 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Epidemics. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Vaccines industry |
| General subdivision |
Social aspects. |
| 9 (RLIN) |
115773 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Green, Catherine |
| Fuller form of name |
(Catherine Mary), |
| Relator term |
author. |
| 9 (RLIN) |
115766 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Crewe, Deborah, |
| Relator term |
author. |
| 9 (RLIN) |
115774 |
| 945 ## - LOCAL PROCESSING INFORMATION (OCLC) |
|---|
| i |
31111082165091 |
| p |
$22.26 |
| 942 00 - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha issues (borrowed), all copies |
1 |